NGen has approved Supercluster funding for a transformative $4.2 million project led by iVexSol Canada to develop an advanced manufacturing process for lentiviral vectors. These gene-editing reagents are critical components in the manufacturing processes of cell and gene therapies (CGTs), which have been successfully employed to fight cancer and repair a variety of rare and inherited […]
New offices at leading science hub support the Company’s rapid growth following recent investment New facility is in addition to headquarters at Babraham Research Campus, Cambridgeshire, UK and offices in Monmouth Junction, New Jersey, USA Cambridge, UK: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it […]
Biognosys Completes Series G Financing Round to Accelerate its Expansion into Clinical Trials Market
Biognosys closes Series G round with new and existing investors to accelerate implementation of discovery proteomics in clinical trials. SCHLIEREN, (Zurich, Switzerland). Biognosys, a Swiss proteomics company, continues realizing its ambition to enable clinical researchers to directly measure and quantify thousands of proteins from patient tissues in clinical trials by offering its next-generation label-free proteomics technology. […]
Bournemouth, UK: Solentim, the innovator and World leader in Cell Line Development instrumentation, is pleased to announce that it achieved very strong revenue growth and financial results for the first half of 2019. Commenting on the performance, Dr Ian Taylor, Chief Commercial Officer noted “Our results are in line with the current surge in the bioprocessing […]
Grant to Automate Variant Interpretation and Create Platform for Sharing Micropublications Across the Genomics Community Genomenon, Inc., the leading genomic search engine company, announced today that it was awarded a grant by the National Institutes of Health. The Small Business Innovation Research (SBIR) grant, awarded by the National Human Genome Research Institute*, will fund Genomenon’s […]
New Funding, Anticipated to Close at $22 Million, to Fuel Growth of its Regenerative Medicine MSC Manufacturing Platform Worldwide, Scale the Organization, and Accelerate R&D Innovation Frederick, MD, Aug. 6 — RoosterBio Inc, disrupting the market by radically simplifying human mesenchymal stem/stromal cell (hMSC) biomanufacturing, today announced it has raised in excess of $15 million in an initial Series B financing […]
Applied DNA and TheraCann International Sign Term Sheet to Amend Licensing and Cooperation Agreement
Amendments fortify the Agreement, allow revenue recognition, and strengthen the Applied DNA Balance Sheet STONY BROOK, N.Y. – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based (Polymerase Chain Reaction) DNA manufacturing for product authenticity and traceability solutions, today announced that the Company and TheraCann International Benchmark Corporation (“TheraCann”) have signed a […]
Khosla Ventures leads Series A investment in human tissue engineering company Prellis, backing Prellis’ mission to create viable human tissue and organs for research and transplant IMAGE: PRELLIS STRUCTURE TRANSPLANTED ALONE IS SURROUNDED BY SINGLE CELL WALLED CAPILLARIES WITHIN TWO WEEKS OF TRANSPLANTATION INTO IMMUNOCOMPETENT MOUSE (LEFT). HUMAN TUMOR CELLS TRANSPLANTED IN PRELLIS STRUCTURES GROW RAPIDLY, […]
Southborough, MA Block MEMS, a leading developer of Quantum Cascade Laser (QCL) based infrared detection systems, has been awarded a $3.5M contract from the Defense Advanced Research Agency (DARPA), as part of the SIGMA+ Program. The goal of the program is to develop a persistent, real-time, early detection system for the full spectrum of chemical, […]
Khosla Ventures leads Series A investment in human tissue engineering company Prellis, backing Prellis’ mission to create viable human tissue and organs for research and transplant San Francisco, CA–Prellis Biologics today announced that Khosla Ventures has led an $8.7 million Series A investment in the company. The announcement comes as Prellis has reached major tissue engineering […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
